| Literature DB >> 19759875 |
Mariana Bueno1, Maria Meimei Brevidelli, Thaís Cocarelli, Gianni Mara Silva dos Santos, Maria Auxiliadora Ferraz, Décio Mion.
Abstract
INTRODUCTION: It is important to know the reasons for resubmitting research projects to the Research Ethics Committee in order to help researchers to prepare their research projects, informed consent forms and needed research documentation.Entities:
Keywords: Bioethics; Ethics in research; Research ethics committee
Mesh:
Year: 2009 PMID: 19759875 PMCID: PMC2745136 DOI: 10.1590/S1807-59322009000900002
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
Research areas
| Research areas | N | % |
|---|---|---|
| Cardiology/Pulmonology | 45 | 12.6 |
| General Medicine | 35 | 9.8 |
| Psychiatry/Psychology | 26 | 7.3 |
| Gynecology/Obstetrics | 25 | 7.0 |
| Ophthalmology/Otorhinolaryingology | 25 | 7.0 |
| Surgery | 23 | 6.5 |
| Neurology | 23 | 6.5 |
| Pediatrics | 21 | 5.9 |
| Physiotherapy/Phonoaudiology/Occupational Therapy | 19 | 5.3 |
| Gastroenterology | 18 | 5.1 |
| Radiology/Radiotherapy | 15 | 4.2 |
| Orthopedics/Traumatology | 14 | 3.9 |
| Pathology | 14 | 3.9 |
| Dermatology | 09 | 2.5 |
| Infectious and Parasitic Diseases | 08 | 2.2 |
| Preventive Medicine | 07 | 2.0 |
| Others | 30 | 8.4 |
Research in special thematic areas
| Thematic areas | N | % |
|---|---|---|
| New drugs, vaccines and diagnostic tests | 51 | 42.5 |
| New procedures | 26 | 21.7 |
| Human genetics | 23 | 19.2 |
| Foreign participation | 12 | 10.0 |
| Biosecurity | 06 | 5.0 |
| Human reproduction | 02 | 1.7 |
Informed consent-related reasons for returning research projects to the researchers
| N | % | |
|---|---|---|
| Inadequate language and/or difficulty of understanding | 136 | 32.2 |
| Lack of information about the protocol | 109 | 25.8 |
| Incomplete/inaccurate filling out form | 39 | 9.2 |
| Lack of information on researcher contacts | 32 | 7.6 |
| Lack of or poor explanation about monetary compensation | 28 | 6.6 |
| Doubts and/or divergence about research’s risk classification | 22 | 5.2 |
| No explanation whether participation in study is voluntary | 14 | 3.3 |
| Lack of or incomplete information on confidentiality | 9 | 2.1 |
| Lack of or incomplete information related to treatment in case of occurrence of adverse events | 7 | 1.7 |
| Lack of or incomplete explanation of risks of procedures involved in the study | 7 | 1.7 |
| Divergence between protocol and informed consent | 6 | 1.4 |
| Lack of or incomplete information of reimbursement | 4 | 0.9 |
| Different versions submitted | 3 | 0.7 |
| Lack of or incomplete information about access to medication at the end of the study | 2 | 0.5 |
| Unidentified | 4 | 0.9 |
Protocol-related reasons for returning research projects to the researchers
| N | % | |
|---|---|---|
| Doubts about methodology and/or statistics | 158 | 77.1 |
| Lack of or incomplete information regarding the risks/benefits of the research | 16 | 7.8 |
| Lack/failure of justification for study | 11 | 5.4 |
| Doubts about use of medication/placebo and/or supply of medication after end of study | 5 | 2.4 |
| Incomplete protocol | 5 | 2.4 |
| Doubts related to foreign participation | 3 | 1.5 |
| Doubts related to ethical validity of research | 3 | 1.5 |
| Presentation of different versions | 2 | 1.0 |
| Doubts related to research volunteer compensation | 1 | 0.5 |
| Unidentified | 1 | 0.5 |
Research project documentation-related reasons for research projects return to the researchers
| N | % | |
|---|---|---|
| Clarification and/or letter of agreement needed of participation of external entities | 24 | 35.3 |
| Lack of documentation of the researcher and/or the research team | 11 | 16.2 |
| Failure to send documentation and/or | 7 | 10.3 |
| Lack of REC approval of the institution that coordinates the research | 6 | 8.8 |
| Lack of approval of the department in charge of the study | 6 | 8.8 |
| Lack of documentation referring to insurance/indemnity | 4 | 5.9 |
| Divergent information in different documents | 3 | 4.4 |
| Clarification needed on medication registration | 2 | 2.9 |
| Lack of confidentiality statement | 2 | 2.9 |
| Clarification needed on sending biological material abroad | 1 | 1.5 |
| Lack of documentation on transportation of biological material | 1 | 1.5 |
| Lack of documentation on previous studies | 1 | 1.5 |
Other reasons for returning the research projects to the researchers related to registration of the researcher and/or the research, schedule, financing and cover page
| Registration | N | % |
|---|---|---|
| Incomplete/inaccuracy of registration form | 32 | 49.2 |
| Discrepant information on the research team | 15 | 23.1 |
| Clarification needed on link between researcher and institution | 8 | 12.3 |
| Discrepant information in different documents | 8 | 12.3 |
| Unidentified | 2 | 3.1 |
| TOTAL | 65 | 100 |
| Lack/inaccuracy of execution schedule | 14 | 66.7 |
| Beginning estimated prior to approval by | 7 | 33.3 |
| No mention of financial support | 6 | 40.0 |
| Clarification on items to be financed | 4 | 26.7 |
| Lack of details on type of financial support | 2 | 13.3 |
| Discrepancies between amounts presented by researcher and sponsor | 2 | 13.3 |
| Clarification on budget management | 1 | 6.7 |
| Missing signatures | 2 | 50.0 |
| Incorrect research area | 1 | 25.0 |
| Discrepant information in different documents | 1 | 25.0 |